BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38641599)

  • 1. Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R.
    Ackmann J; Brüge A; Gotina L; Lim S; Jahreis K; Vollbrecht AL; Kim YK; Pae AN; Labus J; Ponimaskin E
    Cell Commun Signal; 2024 Apr; 22(1):233. PubMed ID: 38641599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of Tau pathology and memory deficits by targeting 5-HT7 receptor.
    Labus J; Röhrs KF; Ackmann J; Varbanov H; Müller FE; Jia S; Jahreis K; Vollbrecht AL; Butzlaff M; Schill Y; Guseva D; Böhm K; Kaushik R; Bijata M; Marin P; Chaumont-Dubel S; Zeug A; Dityatev A; Ponimaskin E
    Prog Neurobiol; 2021 Feb; 197():101900. PubMed ID: 32841723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites.
    Kimura T; Tsutsumi K; Taoka M; Saito T; Masuda-Suzukake M; Ishiguro K; Plattner F; Uchida T; Isobe T; Hasegawa M; Hisanaga SI
    J Biol Chem; 2013 Mar; 288(11):7968-7977. PubMed ID: 23362255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride as a potential disease-modifying drug in the treatment of tauopathies.
    Jahreis K; Brüge A; Borsdorf S; Müller FE; Sun W; Jia S; Kang DM; Boesen N; Shin S; Lim S; Koroleva A; Satała G; Bojarski AJ; Rakuša E; Fink A; Doblhammer-Reiter G; Kim YK; Dityatev A; Ponimaskin E; Labus J
    Alzheimers Dement; 2023 Dec; 19(12):5482-5497. PubMed ID: 37218673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
    Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
    Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain.
    Lu Y; Li T; Qureshi HY; Han D; Paudel HK
    J Biol Chem; 2011 Jun; 286(23):20569-81. PubMed ID: 21489990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
    Tanaka T; Ohashi S; Takashima A; Kobayashi S
    Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons.
    Speranza L; Labus J; Volpicelli F; Guseva D; Lacivita E; Leopoldo M; Bellenchi GC; di Porzio U; Bijata M; Perrone-Capano C; Ponimaskin E
    J Neurochem; 2017 Jun; 141(5):647-661. PubMed ID: 28122114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB; Otth C; Concha II; Muñoz JP
    Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
    Lopes JP; Oliveira CR; Agostinho P
    Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
    Plattner F; Angelo M; Giese KP
    J Biol Chem; 2006 Sep; 281(35):25457-65. PubMed ID: 16803897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
    Chatterjee S; Sang TK; Lawless GM; Jackson GR
    Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator.
    Chou KC; Watenpaugh KD; Heinrikson RL
    Biochem Biophys Res Commun; 1999 Jun; 259(2):420-8. PubMed ID: 10362524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pathological phosphorylation of tau by Cdk5.
    Kimura T; Ishiguro K; Hisanaga S
    Front Mol Neurosci; 2014; 7():65. PubMed ID: 25076872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
    Han P; Dou F; Li F; Zhang X; Zhang YW; Zheng H; Lipton SA; Xu H; Liao FF
    J Neurosci; 2005 Dec; 25(50):11542-52. PubMed ID: 16354912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach.
    Castro-Alvarez JF; Uribe-Arias SA; Mejía-Raigosa D; Cardona-Gómez GP
    Front Aging Neurosci; 2014; 6():232. PubMed ID: 25225483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
    Shukla V; Skuntz S; Pant HC
    Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.